KYMERA THERAPEUTICS INC (KYMR)
US5015751044 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -154.62M | -146.96M | -154.81M | -100.22M | -45.59M | |||
| Depreciation Amortization | 4.13M | 3.56M | 2.98M | 2.40M | 1.76M | |||
| Change In Working Capital | 8.37M | 2.68M | -37.62M | -61.92M | 124.87M | |||
| Interest Paid | 111.00K | 162.00K | 180.00K | 160.00K | 120.00K | |||
| Other non cash items | 43.61M | 37.89M | 36.37M | 30.80M | 7.09M | |||
| OPERATING CASH FLOW | -98.42M | -102.83M | -153.09M | -128.95M | 88.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -37.88M | -34.48M | -2.84M | -1.60M | -9.10M | |||
| Other Investing Activity | -177.44M | 174.37M | 23.36M | -98.24M | -413.49M | |||
| INVESTING CASH FLOW | -215.32M | 139.89M | 20.52M | -99.84M | -422.59M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -66.00K | -76.00K | -1.13M | -850.00K | -550.00K | |||
| Stock Issued/Repurchased | 356.81M | 4.27M | 154.13M | 249.18M | 276.29M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 1.95M | 13.53M | |||
| FINANCING CASH FLOW | 356.75M | 4.19M | 153.00M | 250.28M | 289.26M | |||
| CHANGE IN CASH | 43.01M | 41.25M | 20.43M | 21.49M | -45.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -98.42M | -102.83M | -153.09M | -128.95M | 88.13M | |||
| Capital Expenditure | -37.88M | -34.48M | -2.84M | -1.60M | -9.10M | |||
| FREE CASH FLOW | -136.30M | -137.31M | -155.93M | -130.55M | 79.03M | |||
All data in USD